July 29, 2024
A research team led by UC San Diego has, for the first time, shown that a wearable, non-invasive device can measure activity in human cervical nerves in clinical settings. The results could help medical professionals tailor treatments for inflammatory conditions like sepsis and PTSD.
January 15, 2018
A team of researchers has developed an ultrasound-based system that can non-invasively and remotely control genetic processes in live immune T cells so that they recognize and kill cancer cells.
February 8, 2024
Each cell features mtDNA, instructions that mitochondria use to create energy. When mtDNA remains where it belongs, cells remain healthy. But when it goes where it doesn’t belong, mtDNA can initiate an immune response and inflammation. Scientists have discovered the pathways behind this process.
January 16, 2020
An international team of scientists has synthetically engineered mosquitoes that halt the transmission of the dengue virus. The development marks the first engineered approach in mosquitoes that targets the four known types of dengue, improving upon previous designs that addressed single strains.
June 16, 2021
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they’re needed.
December 9, 2019
Scientists have found the most effective CRISPR shield ever discovered in viruses. They discovered a remarkable new strategy that some bacteria-killing viruses, or phages, employ: after they infect bacteria, these phages construct an impenetrable “safe room” inside of their host.
May 27, 2021
Jack E. Dixon, whose distinguished and varied 48-year career ranged from helping reveal how cells communicate to becoming a renowned scientific leader at UC San Diego School of Medicine and Howard Hughes Medical Institute, is retiring.
October 2, 2018
Three researchers at the University of California San Diego have been selected to receive 2018 NIH Director’s New Innovator Awards. In addition, David Traver from the UC San Diego School of Medicine, has received an NIH Director’s Transformative award.
July 9, 2020
Researchers at University of California San Diego School of Medicine and UC San Diego Health have launched a clinical trial to assess the safety and efficacy of convalescent plasma (CP) to prevent COVID-19 after a known exposure to the virus.
December 1, 2020
Researchers from UC San Diego and UC Santa Barbara combine physics and biology to find that the physical environment where cells migrate through tight spaces is worth considering when studying conditions like development of the brain or movement of immune cells through lymph nodes and tumors.
